176 related articles for article (PubMed ID: 15905187)
1. The heparin-binding site of antithrombin is crucial for antiangiogenic activity.
Zhang W; Swanson R; Izaguirre G; Xiong Y; Lau LF; Olson ST
Blood; 2005 Sep; 106(5):1621-8. PubMed ID: 15905187
[TBL] [Abstract][Full Text] [Related]
2. Antiangiogenic antithrombin blocks the heparan sulfate-dependent binding of proangiogenic growth factors to their endothelial cell receptors: evidence for differential binding of antiangiogenic and anticoagulant forms of antithrombin to proangiogenic heparan sulfate domains.
Zhang W; Swanson R; Xiong Y; Richard B; Olson ST
J Biol Chem; 2006 Dec; 281(49):37302-10. PubMed ID: 17040907
[TBL] [Abstract][Full Text] [Related]
3. Antiangiogenic function of antithrombin is dependent on its conformational variation: implication for other serpins.
Azhar A; Singh P; Rashid Q; Naseem A; Khan MS; Jairajpuri MA
Protein Pept Lett; 2013 Apr; 20(4):403-11. PubMed ID: 23016581
[TBL] [Abstract][Full Text] [Related]
4. Antiangiogenic antithrombin down-regulates the expression of the proangiogenic heparan sulfate proteoglycan, perlecan, in endothelial cells.
Zhang W; Chuang YJ; Swanson R; Li J; Seo K; Leung L; Lau LF; Olson ST
Blood; 2004 Feb; 103(4):1185-91. PubMed ID: 14563633
[TBL] [Abstract][Full Text] [Related]
5. Antiangiogenic forms of antithrombin specifically bind to the anticoagulant heparin sequence.
Schedin-Weiss S; Richard B; Hjelm R; Olson ST
Biochemistry; 2008 Dec; 47(51):13610-9. PubMed ID: 19035835
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the conformational alterations, reduced anticoagulant activity, and enhanced antiangiogenic activity of prelatent antithrombin.
Richard B; Swanson R; Schedin-Weiss S; Ramirez B; Izaguirre G; Gettins PG; Olson ST
J Biol Chem; 2008 May; 283(21):14417-29. PubMed ID: 18375953
[TBL] [Abstract][Full Text] [Related]
7. Oxidized antithrombin is a dual inhibitor of coagulation and angiogenesis: Importance of low heparin affinity.
Azhar A; Khan MS; Swaminathan A; Naseem A; Chatterjee S; Jairajpuri MA
Int J Biol Macromol; 2016 Jan; 82():541-50. PubMed ID: 26554332
[TBL] [Abstract][Full Text] [Related]
8. Antiangiogenic antithrombin induces global changes in the gene expression profile of endothelial cells.
Zhang W; Chuang YJ; Jin T; Swanson R; Xiong Y; Leung L; Olson ST
Cancer Res; 2006 May; 66(10):5047-55. PubMed ID: 16707426
[TBL] [Abstract][Full Text] [Related]
9. A novel anti-angiogenic form of antithrombin with retained proteinase binding ability and heparin affinity.
Larsson H; Akerud P; Nordling K; Raub-Segall E; Claesson-Welsh L; Björk I
J Biol Chem; 2001 Apr; 276(15):11996-2002. PubMed ID: 11278631
[TBL] [Abstract][Full Text] [Related]
10. The antithrombin P1 residue is important for target proteinase specificity but not for heparin activation of the serpin. Characterization of P1 antithrombin variants with altered proteinase specificity but normal heparin activation.
Chuang YJ; Swanson R; Raja SM; Bock SC; Olson ST
Biochemistry; 2001 Jun; 40(22):6670-9. PubMed ID: 11380262
[TBL] [Abstract][Full Text] [Related]
11. Cooperative Interactions of Three Hotspot Heparin Binding Residues Are Critical for Allosteric Activation of Antithrombin by Heparin.
Richard B; Swanson R; Izaguirre G; Olson ST
Biochemistry; 2018 Apr; 57(15):2211-2226. PubMed ID: 29561141
[TBL] [Abstract][Full Text] [Related]
12. Antiangiogenic effects of latent antithrombin through perturbed cell-matrix interactions and apoptosis of endothelial cells.
Larsson H; Sjöblom T; Dixelius J; Ostman A; Ylinenjärvi K; Björk I; Claesson-Welsh L
Cancer Res; 2000 Dec; 60(23):6723-9. PubMed ID: 11118058
[TBL] [Abstract][Full Text] [Related]
13. The signature 3-O-sulfo group of the anticoagulant heparin sequence is critical for heparin binding to antithrombin but is not required for allosteric activation.
Richard B; Swanson R; Olson ST
J Biol Chem; 2009 Oct; 284(40):27054-64. PubMed ID: 19661062
[TBL] [Abstract][Full Text] [Related]
14. Kinetic evidence that allosteric activation of antithrombin by heparin is mediated by two sequential conformational changes.
Schedin-Weiss S; Richard B; Olson ST
Arch Biochem Biophys; 2010 Dec; 504(2):169-76. PubMed ID: 20816747
[TBL] [Abstract][Full Text] [Related]
15. The region of antithrombin interacting with full-length heparin chains outside the high-affinity pentasaccharide sequence extends to Lys136 but not to Lys139.
Arocas V; Turk B; Bock SC; Olson ST; Björk I
Biochemistry; 2000 Jul; 39(29):8512-8. PubMed ID: 10913257
[TBL] [Abstract][Full Text] [Related]
16. Antiangiogenic antithrombin.
O'Reilly MS
Semin Thromb Hemost; 2007 Oct; 33(7):660-6. PubMed ID: 18000792
[TBL] [Abstract][Full Text] [Related]
17. Interaction of antithrombin with sulfated, low molecular weight lignins: opportunities for potent, selective modulation of antithrombin function.
Henry BL; Connell J; Liang A; Krishnasamy C; Desai UR
J Biol Chem; 2009 Jul; 284(31):20897-908. PubMed ID: 19497853
[TBL] [Abstract][Full Text] [Related]
18. Roles of N-terminal region residues Lys11, Arg13, and Arg24 of antithrombin in heparin recognition and in promotion and stabilization of the heparin-induced conformational change.
Schedin-Weiss S; Desai UR; Bock SC; Olson ST; Björk I
Biochemistry; 2004 Jan; 43(3):675-83. PubMed ID: 14730971
[TBL] [Abstract][Full Text] [Related]
19. Importance of lysine 125 for heparin binding and activation of antithrombin.
Schedin-Weiss S; Desai UR; Bock SC; Gettins PG; Olson ST; Björk I
Biochemistry; 2002 Apr; 41(15):4779-88. PubMed ID: 11939772
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms of antithrombin-heparin regulation of blood clotting proteinases. A paradigm for understanding proteinase regulation by serpin family protein proteinase inhibitors.
Olson ST; Richard B; Izaguirre G; Schedin-Weiss S; Gettins PG
Biochimie; 2010 Nov; 92(11):1587-96. PubMed ID: 20685328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
